Free Trial

Codexis (CDXS) Competitors

Codexis logo
$4.33 +0.08 (+1.88%)
(As of 11/20/2024 ET)

CDXS vs. FF, GPRE, AMRS, REX, WLKP, MYGN, NVAX, INVA, OPK, and IRWD

Should you be buying Codexis stock or one of its competitors? The main competitors of Codexis include FutureFuel (FF), Green Plains (GPRE), Amyris (AMRS), REX American Resources (REX), Westlake Chemical Partners (WLKP), Myriad Genetics (MYGN), Novavax (NVAX), Innoviva (INVA), OPKO Health (OPK), and Ironwood Pharmaceuticals (IRWD).

Codexis vs.

FutureFuel (NYSE:FF) and Codexis (NASDAQ:CDXS) are both small-cap oils/energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, community ranking, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

Codexis received 110 more outperform votes than FutureFuel when rated by MarketBeat users. However, 68.57% of users gave FutureFuel an outperform vote while only 61.40% of users gave Codexis an outperform vote.

CompanyUnderperformOutperform
FutureFuelOutperform Votes
240
68.57%
Underperform Votes
110
31.43%
CodexisOutperform Votes
350
61.40%
Underperform Votes
220
38.60%

FutureFuel currently has a consensus price target of $0.80, suggesting a potential downside of 84.42%. Codexis has a consensus price target of $8.33, suggesting a potential upside of 92.46%. Given Codexis' higher probable upside, analysts plainly believe Codexis is more favorable than FutureFuel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FutureFuel
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Codexis
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

FutureFuel has a net margin of 13.18% compared to Codexis' net margin of -96.35%. FutureFuel's return on equity of 15.32% beat Codexis' return on equity.

Company Net Margins Return on Equity Return on Assets
FutureFuel13.18% 15.32% 11.55%
Codexis -96.35%-71.56%-38.00%

44.6% of FutureFuel shares are owned by institutional investors. Comparatively, 78.5% of Codexis shares are owned by institutional investors. 41.1% of FutureFuel shares are owned by company insiders. Comparatively, 2.1% of Codexis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

FutureFuel has higher revenue and earnings than Codexis. Codexis is trading at a lower price-to-earnings ratio than FutureFuel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FutureFuel$368.25M0.61$37.38M$0.826.26
Codexis$64.45M5.47-$76.24M-$0.87-4.98

FutureFuel has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500. Comparatively, Codexis has a beta of 2.07, meaning that its share price is 107% more volatile than the S&P 500.

In the previous week, Codexis had 2 more articles in the media than FutureFuel. MarketBeat recorded 7 mentions for Codexis and 5 mentions for FutureFuel. FutureFuel's average media sentiment score of 0.51 beat Codexis' score of 0.18 indicating that FutureFuel is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
FutureFuel
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Codexis
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

FutureFuel beats Codexis on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDXS vs. The Competition

MetricCodexisIndustrial organic chemicals IndustryMedical SectorNASDAQ Exchange
Market Cap$352.37M$2.91B$5.01B$8.81B
Dividend YieldN/A3.46%5.16%4.06%
P/E Ratio-4.9815.62134.3717.77
Price / Sales5.471,123.661,158.6875.18
Price / CashN/A23.0133.5332.53
Price / Book3.491.604.674.68
Net Income-$76.24M$8.53M$119.07M$226.08M
7 Day Performance15.78%-1.62%-1.83%-1.04%
1 Month Performance31.61%-12.63%-3.62%1.04%
1 Year Performance125.52%-13.30%31.63%26.28%

Codexis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CDXS
Codexis
4.1964 of 5 stars
$4.33
+1.9%
$8.33
+92.5%
+117.6%$352.37M$64.45M-4.98250
FF
FutureFuel
4.4216 of 5 stars
$5.14
-1.3%
$0.80
-84.4%
-17.0%$224.71M$368.25M6.26515Analyst Downgrade
GPRE
Green Plains
2.6189 of 5 stars
$10.88
+3.1%
$25.50
+134.4%
-58.1%$682.07M$2.59B-28.63921Analyst Downgrade
AMRS
Amyris
N/AN/AN/AN/A$18.47M$269.85M-0.031,598High Trading Volume
REX
REX American Resources
3.4771 of 5 stars
$44.80
+1.9%
$60.00
+33.9%
+19.5%$787.14M$833.38M11.40117Positive News
WLKP
Westlake Chemical Partners
3.4889 of 5 stars
$22.71
+0.5%
N/A+2.9%$796.39M$1.19B12.98150High Trading Volume
MYGN
Myriad Genetics
4.252 of 5 stars
$15.30
+2.0%
$27.36
+78.8%
-15.3%$1.37B$753.20M0.002,700Analyst Forecast
NVAX
Novavax
3.672 of 5 stars
$8.06
+0.8%
$17.83
+121.3%
+41.4%$1.28B$983.71M0.001,543Analyst Revision
INVA
Innoviva
1.0402 of 5 stars
$19.15
+0.3%
N/A+40.6%$1.20B$310.46M27.75112News Coverage
High Trading Volume
OPK
OPKO Health
4.458 of 5 stars
$1.58
-2.5%
$2.75
+74.1%
+6.8%$1.08B$863.50M-8.323,930
IRWD
Ironwood Pharmaceuticals
4.2622 of 5 stars
$3.52
-7.6%
$10.40
+195.5%
-63.0%$563.31M$442.73M-117.33220

Related Companies and Tools


This page (NASDAQ:CDXS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners